IBIO Stock Analysis: Buy, Sell, or Hold?
IBIO - iBio, Inc. Common Stock
$1.43
-0.04 (-2.72%)
▼
5d:
+0.0%
30d:
+2.14%
90d:
-24.34%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Sep 04, 2026
10d
Get Alerted When IBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: IBIO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: IBIO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: IBIO is currently trading at $1.43, which is considered extended relative to its 30-day fair value range of $1.38 to $1.46.
Technical Outlook: Technically, IBIO is in a strong downtrend. Immediate support is located at $1.34, while resistance sits at $1.54.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.40 (+277.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IBIO is in a strong downtrend. Immediate support is located at $1.34, while resistance sits at $1.54.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.40 (+277.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.38 -
$1.46
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
51.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (46/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 277.6% below Wall St target ($5.40)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.38 -
$1.46
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.34
Resistance Level
$1.54
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.61
Wall Street Target
$5.40
(+277.6%)
Revenue Growth (YoY)
14.3%
Share & Embed Analysis
Last updated: August 24, 2026 9:21 AM ET
Data refreshes hourly during market hours. Next update: 10:21 AM
Data refreshes hourly during market hours. Next update: 10:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IBIO showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Felipe Duran
BUY
24835 shares
2026-03-19
Martin Brenner
BUY
12336 shares
2026-03-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 35 SELL |
